BLFS
BIOLIFE SOLUTIONS INC
Key Financials
Net Income
$-4595000
↑ 77.2%
Gross Profit
$62.1M
↑ 24.0%
Operating Income
$-16602000
↓ 132.9%
Revenue
$6.2M
↓ 30.8%
EPS (Diluted)
$-0.10
↑ 77.3%
Total Assets
$405.9M
↑ 1.6%
Total Liabilities
$34.0M
↓ 32.8%
Cash & Equivalents
$33.0M
↓ 65.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/10/2026 | View on SEC |
| 4 | 4/10/2026 | View on SEC |
| 4 | 4/10/2026 | View on SEC |
| 4 | 3/31/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 4 | 3/23/2026 | View on SEC |
| 4 | 3/23/2026 | View on SEC |
| 4 | 3/23/2026 | View on SEC |
| 4 | 3/23/2026 | View on SEC |
| 4 | 3/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BLFS |
| Company Name | BIOLIFE SOLUTIONS INC |
| CIK | 834365 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 4254011400 |